nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC22A5—Dactinomycin—melanoma	0.189	0.735	CbGbCtD
Niacin—CYP2D6—Vemurafenib—melanoma	0.0679	0.265	CbGbCtD
Niacin—NNMT—optic choroid—melanoma	0.0299	0.264	CbGeAlD
Niacin—SLC16A3—optic choroid—melanoma	0.0204	0.181	CbGeAlD
Niacin—HCAR2—skin of body—melanoma	0.00931	0.0823	CbGeAlD
Niacin—QPRT—head—melanoma	0.00725	0.0641	CbGeAlD
Niacin—NNMT—eye—melanoma	0.00602	0.0532	CbGeAlD
Niacin—NNMT—mammalian vulva—melanoma	0.00478	0.0422	CbGeAlD
Niacin—HCAR2—lymph node—melanoma	0.00425	0.0376	CbGeAlD
Niacin—SLC16A3—eye—melanoma	0.00411	0.0363	CbGeAlD
Niacin—SLC16A3—retina—melanoma	0.00407	0.036	CbGeAlD
Niacin—NNMT—head—melanoma	0.00342	0.0302	CbGeAlD
Niacin—SLC16A1—eye—melanoma	0.0025	0.0221	CbGeAlD
Niacin—SLC16A1—retina—melanoma	0.00247	0.0219	CbGeAlD
Niacin—NNMT—lymph node—melanoma	0.00239	0.0212	CbGeAlD
Niacin—SLC16A3—head—melanoma	0.00233	0.0206	CbGeAlD
Niacin—SLC16A3—lymph node—melanoma	0.00163	0.0144	CbGeAlD
Niacin—SLC16A1—head—melanoma	0.00142	0.0125	CbGeAlD
Niacin—SLC22A5—retina—melanoma	0.00141	0.0125	CbGeAlD
Niacin—SLC22A5—skin of body—melanoma	0.00124	0.011	CbGeAlD
Niacin—SLCO2B1—head—melanoma	0.00122	0.0108	CbGeAlD
Niacin—Malnutrition—Vemurafenib—melanoma	0.00113	0.00381	CcSEcCtD
Niacin—Necrosis—Docetaxel—melanoma	0.00112	0.00378	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000994	0.00335	CcSEcCtD
Niacin—SLC16A1—lymph node—melanoma	0.000993	0.00878	CbGeAlD
Niacin—Cough—Vemurafenib—melanoma	0.000988	0.00333	CcSEcCtD
Niacin—Liver function test abnormal—Dactinomycin—melanoma	0.000981	0.0033	CcSEcCtD
Niacin—Bone disorder—Docetaxel—melanoma	0.000975	0.00328	CcSEcCtD
Niacin—Hyperbilirubinaemia—Docetaxel—melanoma	0.000968	0.00326	CcSEcCtD
Niacin—Myalgia—Vemurafenib—melanoma	0.000964	0.00324	CcSEcCtD
Niacin—Arthralgia—Vemurafenib—melanoma	0.000964	0.00324	CcSEcCtD
Niacin—Face oedema—Carmustine—melanoma	0.00096	0.00323	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000957	0.00322	CcSEcCtD
Niacin—Face oedema—Temozolomide—melanoma	0.000928	0.00312	CcSEcCtD
Niacin—Anaphylactic shock—Vemurafenib—melanoma	0.000924	0.00311	CcSEcCtD
Niacin—Dysphagia—Dactinomycin—melanoma	0.000918	0.00309	CcSEcCtD
Niacin—Liver function test abnormal—Carmustine—melanoma	0.000918	0.00309	CcSEcCtD
Niacin—Skin disorder—Vemurafenib—melanoma	0.000898	0.00302	CcSEcCtD
Niacin—Dry skin—Temozolomide—melanoma	0.000881	0.00296	CcSEcCtD
Niacin—Muscular weakness—Carmustine—melanoma	0.000877	0.00295	CcSEcCtD
Niacin—Hypotension—Vemurafenib—melanoma	0.000863	0.00291	CcSEcCtD
Niacin—Dysphagia—Carmustine—melanoma	0.000859	0.00289	CcSEcCtD
Niacin—Stomatitis—Bleomycin—melanoma	0.000856	0.00288	CcSEcCtD
Niacin—SLCO2B1—lymph node—melanoma	0.000854	0.00755	CbGeAlD
Niacin—Muscular weakness—Temozolomide—melanoma	0.000847	0.00285	CcSEcCtD
Niacin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000842	0.00283	CcSEcCtD
Niacin—Skin exfoliation—Docetaxel—melanoma	0.00084	0.00283	CcSEcCtD
Niacin—Abdominal distension—Temozolomide—melanoma	0.000836	0.00281	CcSEcCtD
Niacin—Fluid retention—Docetaxel—melanoma	0.000836	0.00281	CcSEcCtD
Niacin—Dysphagia—Temozolomide—melanoma	0.00083	0.0028	CcSEcCtD
Niacin—Oesophagitis—Docetaxel—melanoma	0.000804	0.00271	CcSEcCtD
Niacin—Decreased appetite—Vemurafenib—melanoma	0.000803	0.0027	CcSEcCtD
Niacin—Bronchitis—Temozolomide—melanoma	0.000799	0.00269	CcSEcCtD
Niacin—Stomatitis—Dactinomycin—melanoma	0.000798	0.00269	CcSEcCtD
Niacin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000798	0.00269	CcSEcCtD
Niacin—Haemoglobin—Bleomycin—melanoma	0.000792	0.00267	CcSEcCtD
Niacin—Haemorrhage—Bleomycin—melanoma	0.000788	0.00265	CcSEcCtD
Niacin—Hypoaesthesia—Bleomycin—melanoma	0.000784	0.00264	CcSEcCtD
Niacin—Erectile dysfunction—Temozolomide—melanoma	0.000765	0.00257	CcSEcCtD
Niacin—Stomatitis—Carmustine—melanoma	0.000747	0.00251	CcSEcCtD
Niacin—Hepatitis—Dactinomycin—melanoma	0.000735	0.00247	CcSEcCtD
Niacin—Flushing—Bleomycin—melanoma	0.000731	0.00246	CcSEcCtD
Niacin—Body temperature increased—Vemurafenib—melanoma	0.00073	0.00246	CcSEcCtD
Niacin—Stomatitis—Temozolomide—melanoma	0.000722	0.00243	CcSEcCtD
Niacin—Chills—Bleomycin—melanoma	0.000707	0.00238	CcSEcCtD
Niacin—Alopecia—Bleomycin—melanoma	0.000696	0.00234	CcSEcCtD
Niacin—Haemoglobin—Carmustine—melanoma	0.000691	0.00233	CcSEcCtD
Niacin—Haemorrhage—Carmustine—melanoma	0.000688	0.00232	CcSEcCtD
Niacin—Erythema—Bleomycin—melanoma	0.000686	0.00231	CcSEcCtD
Niacin—Hypoaesthesia—Carmustine—melanoma	0.000684	0.0023	CcSEcCtD
Niacin—Flushing—Dactinomycin—melanoma	0.000682	0.0023	CcSEcCtD
Niacin—Hypersensitivity—Vemurafenib—melanoma	0.000681	0.00229	CcSEcCtD
Niacin—Oedema peripheral—Carmustine—melanoma	0.000678	0.00228	CcSEcCtD
Niacin—Atrial fibrillation—Docetaxel—melanoma	0.000674	0.00227	CcSEcCtD
Niacin—Dermatitis bullous—Docetaxel—melanoma	0.000669	0.00225	CcSEcCtD
Niacin—Haemoglobin—Temozolomide—melanoma	0.000668	0.00225	CcSEcCtD
Niacin—Haemorrhage—Temozolomide—melanoma	0.000665	0.00224	CcSEcCtD
Niacin—Hepatitis—Temozolomide—melanoma	0.000665	0.00224	CcSEcCtD
Niacin—Asthenia—Vemurafenib—melanoma	0.000663	0.00223	CcSEcCtD
Niacin—Visual impairment—Carmustine—melanoma	0.000663	0.00223	CcSEcCtD
Niacin—Hypoaesthesia—Temozolomide—melanoma	0.000661	0.00223	CcSEcCtD
Niacin—Chills—Dactinomycin—melanoma	0.000659	0.00222	CcSEcCtD
Niacin—Oedema peripheral—Temozolomide—melanoma	0.000655	0.0022	CcSEcCtD
Niacin—Pruritus—Vemurafenib—melanoma	0.000654	0.0022	CcSEcCtD
Niacin—Alopecia—Dactinomycin—melanoma	0.000649	0.00219	CcSEcCtD
Niacin—Eye disorder—Carmustine—melanoma	0.000643	0.00216	CcSEcCtD
Niacin—Visual impairment—Temozolomide—melanoma	0.000641	0.00216	CcSEcCtD
Niacin—Erythema—Dactinomycin—melanoma	0.00064	0.00215	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000639	0.00215	CcSEcCtD
Niacin—Flushing—Carmustine—melanoma	0.000638	0.00215	CcSEcCtD
Niacin—Diarrhoea—Vemurafenib—melanoma	0.000632	0.00213	CcSEcCtD
Niacin—Migraine—Docetaxel—melanoma	0.000629	0.00212	CcSEcCtD
Niacin—Eye disorder—Temozolomide—melanoma	0.000621	0.00209	CcSEcCtD
Niacin—Tinnitus—Temozolomide—melanoma	0.00062	0.00209	CcSEcCtD
Niacin—Flushing—Temozolomide—melanoma	0.000617	0.00208	CcSEcCtD
Niacin—Arrhythmia—Carmustine—melanoma	0.000614	0.00207	CcSEcCtD
Niacin—Leukopenia—Bleomycin—melanoma	0.000614	0.00207	CcSEcCtD
Niacin—Dizziness—Vemurafenib—melanoma	0.000611	0.00206	CcSEcCtD
Niacin—Alopecia—Carmustine—melanoma	0.000608	0.00205	CcSEcCtD
Niacin—Angiopathy—Temozolomide—melanoma	0.000603	0.00203	CcSEcCtD
Niacin—Malnutrition—Carmustine—melanoma	0.000599	0.00202	CcSEcCtD
Niacin—Erythema—Carmustine—melanoma	0.000599	0.00202	CcSEcCtD
Niacin—Cough—Bleomycin—melanoma	0.000599	0.00201	CcSEcCtD
Niacin—Chills—Temozolomide—melanoma	0.000596	0.00201	CcSEcCtD
Niacin—Liver function test abnormal—Docetaxel—melanoma	0.00059	0.00199	CcSEcCtD
Niacin—Vomiting—Vemurafenib—melanoma	0.000588	0.00198	CcSEcCtD
Niacin—Alopecia—Temozolomide—melanoma	0.000587	0.00198	CcSEcCtD
Niacin—Dry skin—Docetaxel—melanoma	0.000586	0.00197	CcSEcCtD
Niacin—Myalgia—Bleomycin—melanoma	0.000584	0.00197	CcSEcCtD
Niacin—Orthostatic hypotension—Docetaxel—melanoma	0.000584	0.00196	CcSEcCtD
Niacin—Rash—Vemurafenib—melanoma	0.000583	0.00196	CcSEcCtD
Niacin—Dermatitis—Vemurafenib—melanoma	0.000582	0.00196	CcSEcCtD
Niacin—Headache—Vemurafenib—melanoma	0.000579	0.00195	CcSEcCtD
Niacin—Malnutrition—Temozolomide—melanoma	0.000579	0.00195	CcSEcCtD
Niacin—Erythema—Temozolomide—melanoma	0.000579	0.00195	CcSEcCtD
Niacin—Leukopenia—Dactinomycin—melanoma	0.000573	0.00193	CcSEcCtD
Niacin—SLC22A5—lymph node—melanoma	0.000567	0.00501	CbGeAlD
Niacin—Vision blurred—Carmustine—melanoma	0.000564	0.0019	CcSEcCtD
Niacin—Oedema—Bleomycin—melanoma	0.00056	0.00188	CcSEcCtD
Niacin—Anaphylactic shock—Bleomycin—melanoma	0.00056	0.00188	CcSEcCtD
Niacin—Dysphagia—Docetaxel—melanoma	0.000552	0.00186	CcSEcCtD
Niacin—Nausea—Vemurafenib—melanoma	0.000549	0.00185	CcSEcCtD
Niacin—Vision blurred—Temozolomide—melanoma	0.000545	0.00184	CcSEcCtD
Niacin—Myalgia—Dactinomycin—melanoma	0.000545	0.00183	CcSEcCtD
Niacin—Angina pectoris—Docetaxel—melanoma	0.000538	0.00181	CcSEcCtD
Niacin—Leukopenia—Carmustine—melanoma	0.000536	0.0018	CcSEcCtD
Niacin—Anorexia—Bleomycin—melanoma	0.000534	0.0018	CcSEcCtD
Niacin—Angioedema—Temozolomide—melanoma	0.000529	0.00178	CcSEcCtD
Niacin—Hypotension—Bleomycin—melanoma	0.000523	0.00176	CcSEcCtD
Niacin—CYP2D6—head—melanoma	0.000523	0.00462	CbGeAlD
Niacin—Oedema—Dactinomycin—melanoma	0.000522	0.00176	CcSEcCtD
Niacin—Vertigo—Temozolomide—melanoma	0.00052	0.00175	CcSEcCtD
Niacin—Leukopenia—Temozolomide—melanoma	0.000518	0.00174	CcSEcCtD
Niacin—Palpitations—Temozolomide—melanoma	0.000511	0.00172	CcSEcCtD
Niacin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00051	0.00172	CcSEcCtD
Niacin—Myalgia—Carmustine—melanoma	0.00051	0.00172	CcSEcCtD
Niacin—Cough—Temozolomide—melanoma	0.000505	0.0017	CcSEcCtD
Niacin—Paraesthesia—Bleomycin—melanoma	0.000503	0.00169	CcSEcCtD
Niacin—Dyspnoea—Bleomycin—melanoma	0.000499	0.00168	CcSEcCtD
Niacin—Anorexia—Dactinomycin—melanoma	0.000498	0.00168	CcSEcCtD
Niacin—Myalgia—Temozolomide—melanoma	0.000493	0.00166	CcSEcCtD
Niacin—Arthralgia—Temozolomide—melanoma	0.000493	0.00166	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000489	0.00165	CcSEcCtD
Niacin—Oedema—Carmustine—melanoma	0.000489	0.00164	CcSEcCtD
Niacin—Decreased appetite—Bleomycin—melanoma	0.000487	0.00164	CcSEcCtD
Niacin—Dry mouth—Temozolomide—melanoma	0.000482	0.00162	CcSEcCtD
Niacin—Stomatitis—Docetaxel—melanoma	0.00048	0.00162	CcSEcCtD
Niacin—Jaundice—Docetaxel—melanoma	0.00048	0.00162	CcSEcCtD
Niacin—Pain—Bleomycin—melanoma	0.000479	0.00161	CcSEcCtD
Niacin—Tachycardia—Carmustine—melanoma	0.000477	0.00161	CcSEcCtD
Niacin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000476	0.0016	CcSEcCtD
Niacin—Oedema—Temozolomide—melanoma	0.000472	0.00159	CcSEcCtD
Niacin—Anaphylactic shock—Temozolomide—melanoma	0.000472	0.00159	CcSEcCtD
Niacin—Anorexia—Carmustine—melanoma	0.000466	0.00157	CcSEcCtD
Niacin—Skin disorder—Temozolomide—melanoma	0.000459	0.00154	CcSEcCtD
Niacin—Hypotension—Carmustine—melanoma	0.000457	0.00154	CcSEcCtD
Niacin—Hyperhidrosis—Temozolomide—melanoma	0.000457	0.00154	CcSEcCtD
Niacin—Decreased appetite—Dactinomycin—melanoma	0.000454	0.00153	CcSEcCtD
Niacin—Anorexia—Temozolomide—melanoma	0.00045	0.00152	CcSEcCtD
Niacin—Pain—Dactinomycin—melanoma	0.000446	0.0015	CcSEcCtD
Niacin—Musculoskeletal discomfort—Carmustine—melanoma	0.000445	0.0015	CcSEcCtD
Niacin—Urticaria—Bleomycin—melanoma	0.000445	0.0015	CcSEcCtD
Niacin—Haemoglobin—Docetaxel—melanoma	0.000444	0.0015	CcSEcCtD
Niacin—Rhinitis—Docetaxel—melanoma	0.000443	0.00149	CcSEcCtD
Niacin—Body temperature increased—Bleomycin—melanoma	0.000443	0.00149	CcSEcCtD
Niacin—Haemorrhage—Docetaxel—melanoma	0.000442	0.00149	CcSEcCtD
Niacin—Hepatitis—Docetaxel—melanoma	0.000442	0.00149	CcSEcCtD
Niacin—Insomnia—Carmustine—melanoma	0.000442	0.00149	CcSEcCtD
Niacin—Hypoaesthesia—Docetaxel—melanoma	0.00044	0.00148	CcSEcCtD
Niacin—Paraesthesia—Carmustine—melanoma	0.000439	0.00148	CcSEcCtD
Niacin—Dyspnoea—Carmustine—melanoma	0.000436	0.00147	CcSEcCtD
Niacin—Oedema peripheral—Docetaxel—melanoma	0.000435	0.00147	CcSEcCtD
Niacin—Somnolence—Carmustine—melanoma	0.000434	0.00146	CcSEcCtD
Niacin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00043	0.00145	CcSEcCtD
Niacin—Insomnia—Temozolomide—melanoma	0.000427	0.00144	CcSEcCtD
Niacin—Gastrointestinal pain—Dactinomycin—melanoma	0.000427	0.00144	CcSEcCtD
Niacin—Visual impairment—Docetaxel—melanoma	0.000426	0.00143	CcSEcCtD
Niacin—Decreased appetite—Carmustine—melanoma	0.000425	0.00143	CcSEcCtD
Niacin—Paraesthesia—Temozolomide—melanoma	0.000424	0.00143	CcSEcCtD
Niacin—Gastrointestinal disorder—Carmustine—melanoma	0.000422	0.00142	CcSEcCtD
Niacin—Dyspnoea—Temozolomide—melanoma	0.000421	0.00142	CcSEcCtD
Niacin—Somnolence—Temozolomide—melanoma	0.00042	0.00141	CcSEcCtD
Niacin—Pain—Carmustine—melanoma	0.000418	0.00141	CcSEcCtD
Niacin—Dyspepsia—Temozolomide—melanoma	0.000416	0.0014	CcSEcCtD
Niacin—Eye disorder—Docetaxel—melanoma	0.000413	0.00139	CcSEcCtD
Niacin—Abdominal pain—Dactinomycin—melanoma	0.000413	0.00139	CcSEcCtD
Niacin—Body temperature increased—Dactinomycin—melanoma	0.000413	0.00139	CcSEcCtD
Niacin—Hypersensitivity—Bleomycin—melanoma	0.000412	0.00139	CcSEcCtD
Niacin—Decreased appetite—Temozolomide—melanoma	0.000411	0.00138	CcSEcCtD
Niacin—Flushing—Docetaxel—melanoma	0.00041	0.00138	CcSEcCtD
Niacin—Gastrointestinal disorder—Temozolomide—melanoma	0.000408	0.00137	CcSEcCtD
Niacin—Pain—Temozolomide—melanoma	0.000404	0.00136	CcSEcCtD
Niacin—Asthenia—Bleomycin—melanoma	0.000402	0.00135	CcSEcCtD
Niacin—Angiopathy—Docetaxel—melanoma	0.000401	0.00135	CcSEcCtD
Niacin—Gastrointestinal pain—Carmustine—melanoma	0.0004	0.00135	CcSEcCtD
Niacin—Chills—Docetaxel—melanoma	0.000397	0.00134	CcSEcCtD
Niacin—Pruritus—Bleomycin—melanoma	0.000396	0.00133	CcSEcCtD
Niacin—Arrhythmia—Docetaxel—melanoma	0.000395	0.00133	CcSEcCtD
Niacin—Alopecia—Docetaxel—melanoma	0.000391	0.00131	CcSEcCtD
Niacin—Body temperature increased—Carmustine—melanoma	0.000386	0.0013	CcSEcCtD
Niacin—Abdominal pain—Carmustine—melanoma	0.000386	0.0013	CcSEcCtD
Niacin—Gastrointestinal pain—Temozolomide—melanoma	0.000386	0.0013	CcSEcCtD
Niacin—Malnutrition—Docetaxel—melanoma	0.000385	0.0013	CcSEcCtD
Niacin—Erythema—Docetaxel—melanoma	0.000385	0.0013	CcSEcCtD
Niacin—Hypersensitivity—Dactinomycin—melanoma	0.000385	0.00129	CcSEcCtD
Niacin—Urticaria—Temozolomide—melanoma	0.000375	0.00126	CcSEcCtD
Niacin—Asthenia—Dactinomycin—melanoma	0.000375	0.00126	CcSEcCtD
Niacin—Abdominal pain—Temozolomide—melanoma	0.000373	0.00126	CcSEcCtD
Niacin—Body temperature increased—Temozolomide—melanoma	0.000373	0.00126	CcSEcCtD
Niacin—Muscle spasms—Docetaxel—melanoma	0.00037	0.00125	CcSEcCtD
Niacin—Hypersensitivity—Carmustine—melanoma	0.00036	0.00121	CcSEcCtD
Niacin—Diarrhoea—Dactinomycin—melanoma	0.000357	0.0012	CcSEcCtD
Niacin—Vomiting—Bleomycin—melanoma	0.000356	0.0012	CcSEcCtD
Niacin—Rash—Bleomycin—melanoma	0.000353	0.00119	CcSEcCtD
Niacin—Dermatitis—Bleomycin—melanoma	0.000353	0.00119	CcSEcCtD
Niacin—Asthenia—Carmustine—melanoma	0.000351	0.00118	CcSEcCtD
Niacin—Hypersensitivity—Temozolomide—melanoma	0.000348	0.00117	CcSEcCtD
Niacin—Syncope—Docetaxel—melanoma	0.000345	0.00116	CcSEcCtD
Niacin—Leukopenia—Docetaxel—melanoma	0.000344	0.00116	CcSEcCtD
Niacin—Palpitations—Docetaxel—melanoma	0.00034	0.00114	CcSEcCtD
Niacin—Asthenia—Temozolomide—melanoma	0.000339	0.00114	CcSEcCtD
Niacin—Loss of consciousness—Docetaxel—melanoma	0.000338	0.00114	CcSEcCtD
Niacin—Cough—Docetaxel—melanoma	0.000336	0.00113	CcSEcCtD
Niacin—Diarrhoea—Carmustine—melanoma	0.000334	0.00113	CcSEcCtD
Niacin—Pruritus—Temozolomide—melanoma	0.000334	0.00112	CcSEcCtD
Niacin—Nausea—Bleomycin—melanoma	0.000333	0.00112	CcSEcCtD
Niacin—Vomiting—Dactinomycin—melanoma	0.000332	0.00112	CcSEcCtD
Niacin—Rash—Dactinomycin—melanoma	0.000329	0.00111	CcSEcCtD
Niacin—Arthralgia—Docetaxel—melanoma	0.000328	0.0011	CcSEcCtD
Niacin—Myalgia—Docetaxel—melanoma	0.000328	0.0011	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000325	0.0011	CcSEcCtD
Niacin—Dizziness—Carmustine—melanoma	0.000323	0.00109	CcSEcCtD
Niacin—Diarrhoea—Temozolomide—melanoma	0.000323	0.00109	CcSEcCtD
Niacin—Dry mouth—Docetaxel—melanoma	0.00032	0.00108	CcSEcCtD
Niacin—Salicylic acid—PTGS2—melanoma	0.000318	0.365	CrCbGaD
Niacin—Anaphylactic shock—Docetaxel—melanoma	0.000314	0.00106	CcSEcCtD
Niacin—Oedema—Docetaxel—melanoma	0.000314	0.00106	CcSEcCtD
Niacin—Dizziness—Temozolomide—melanoma	0.000312	0.00105	CcSEcCtD
Niacin—Vomiting—Carmustine—melanoma	0.000311	0.00105	CcSEcCtD
Niacin—Nausea—Dactinomycin—melanoma	0.00031	0.00104	CcSEcCtD
Niacin—Shock—Docetaxel—melanoma	0.000309	0.00104	CcSEcCtD
Niacin—Rash—Carmustine—melanoma	0.000308	0.00104	CcSEcCtD
Niacin—Dermatitis—Carmustine—melanoma	0.000308	0.00104	CcSEcCtD
Niacin—Tachycardia—Docetaxel—melanoma	0.000307	0.00103	CcSEcCtD
Niacin—Headache—Carmustine—melanoma	0.000306	0.00103	CcSEcCtD
Niacin—Skin disorder—Docetaxel—melanoma	0.000305	0.00103	CcSEcCtD
Niacin—Vomiting—Temozolomide—melanoma	0.0003	0.00101	CcSEcCtD
Niacin—Anorexia—Docetaxel—melanoma	0.000299	0.00101	CcSEcCtD
Niacin—Rash—Temozolomide—melanoma	0.000298	0.001	CcSEcCtD
Niacin—Dermatitis—Temozolomide—melanoma	0.000297	0.001	CcSEcCtD
Niacin—Headache—Temozolomide—melanoma	0.000296	0.000996	CcSEcCtD
Niacin—Hypotension—Docetaxel—melanoma	0.000293	0.000988	CcSEcCtD
Niacin—Nausea—Carmustine—melanoma	0.00029	0.000977	CcSEcCtD
Niacin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000286	0.000963	CcSEcCtD
Niacin—Insomnia—Docetaxel—melanoma	0.000284	0.000956	CcSEcCtD
Niacin—Salicylic acid—ALB—melanoma	0.000284	0.325	CrCbGaD
Niacin—Paraesthesia—Docetaxel—melanoma	0.000282	0.000949	CcSEcCtD
Niacin—Nausea—Temozolomide—melanoma	0.000281	0.000944	CcSEcCtD
Niacin—Dyspnoea—Docetaxel—melanoma	0.00028	0.000942	CcSEcCtD
Niacin—Somnolence—Docetaxel—melanoma	0.000279	0.00094	CcSEcCtD
Niacin—Dyspepsia—Docetaxel—melanoma	0.000276	0.000931	CcSEcCtD
Niacin—Decreased appetite—Docetaxel—melanoma	0.000273	0.000919	CcSEcCtD
Niacin—Gastrointestinal disorder—Docetaxel—melanoma	0.000271	0.000913	CcSEcCtD
Niacin—Salicylic acid—ABCB1—melanoma	0.000271	0.31	CrCbGaD
Niacin—Pain—Docetaxel—melanoma	0.000269	0.000904	CcSEcCtD
Niacin—Gastrointestinal pain—Docetaxel—melanoma	0.000257	0.000864	CcSEcCtD
Niacin—Abdominal pain—Docetaxel—melanoma	0.000248	0.000836	CcSEcCtD
Niacin—Body temperature increased—Docetaxel—melanoma	0.000248	0.000836	CcSEcCtD
Niacin—Hypersensitivity—Docetaxel—melanoma	0.000231	0.000779	CcSEcCtD
Niacin—Asthenia—Docetaxel—melanoma	0.000225	0.000758	CcSEcCtD
Niacin—Pruritus—Docetaxel—melanoma	0.000222	0.000748	CcSEcCtD
Niacin—Diarrhoea—Docetaxel—melanoma	0.000215	0.000723	CcSEcCtD
Niacin—Dizziness—Docetaxel—melanoma	0.000208	0.000699	CcSEcCtD
Niacin—Vomiting—Docetaxel—melanoma	0.0002	0.000672	CcSEcCtD
Niacin—Rash—Docetaxel—melanoma	0.000198	0.000667	CcSEcCtD
Niacin—Dermatitis—Docetaxel—melanoma	0.000198	0.000666	CcSEcCtD
Niacin—Headache—Docetaxel—melanoma	0.000197	0.000662	CcSEcCtD
Niacin—Nausea—Docetaxel—melanoma	0.000187	0.000628	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—melanoma	7.64e-05	0.00023	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CD—melanoma	7.64e-05	0.00023	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HGF—melanoma	7.61e-05	0.000229	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CUBN—melanoma	7.61e-05	0.000229	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—melanoma	7.58e-05	0.000228	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—melanoma	7.54e-05	0.000227	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CSF2—melanoma	7.52e-05	0.000226	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP17A1—melanoma	7.47e-05	0.000225	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNAQ—melanoma	7.45e-05	0.000224	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CD44—melanoma	7.45e-05	0.000224	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KDR—melanoma	7.41e-05	0.000223	CbGpPWpGaD
Niacin—QPRT—Disease—CDKN1A—melanoma	7.4e-05	0.000223	CbGpPWpGaD
Niacin—QPRT—Disease—PTEN—melanoma	7.39e-05	0.000222	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	7.37e-05	0.000222	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2—melanoma	7.36e-05	0.000222	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HIF1A—melanoma	7.35e-05	0.000221	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SDHD—melanoma	7.35e-05	0.000221	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BSG—melanoma	7.35e-05	0.000221	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CSPG4—melanoma	7.35e-05	0.000221	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ITGB3—melanoma	7.21e-05	0.000217	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PRKCA—melanoma	7.21e-05	0.000217	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	7.18e-05	0.000216	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CB—melanoma	7.16e-05	0.000215	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CYP1B1—melanoma	7.15e-05	0.000215	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FN1—melanoma	7.14e-05	0.000215	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPAM—melanoma	7.12e-05	0.000214	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—melanoma	7.09e-05	0.000213	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KDR—melanoma	7.03e-05	0.000211	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH1—melanoma	6.98e-05	0.00021	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CD80—melanoma	6.84e-05	0.000206	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—melanoma	6.83e-05	0.000205	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KIT—melanoma	6.83e-05	0.000205	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—melanoma	6.83e-05	0.000205	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—NRAS—melanoma	6.83e-05	0.000205	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ABCB1—melanoma	6.79e-05	0.000204	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FN1—melanoma	6.77e-05	0.000204	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGF—melanoma	6.75e-05	0.000203	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAC1—melanoma	6.69e-05	0.000201	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CB—melanoma	6.66e-05	0.0002	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH1—melanoma	6.62e-05	0.000199	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—melanoma	6.61e-05	0.000199	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—melanoma	6.6e-05	0.000198	CbGpPWpGaD
Niacin—QPRT—Disease—NRAS—melanoma	6.59e-05	0.000198	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MAPK3—melanoma	6.54e-05	0.000197	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CD80—melanoma	6.49e-05	0.000195	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KIT—melanoma	6.47e-05	0.000195	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—melanoma	6.47e-05	0.000195	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CG—melanoma	6.47e-05	0.000195	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—NRAS—melanoma	6.47e-05	0.000195	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MMP1—melanoma	6.47e-05	0.000195	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—BRAF—melanoma	6.42e-05	0.000193	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGF—melanoma	6.4e-05	0.000193	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CDK2—melanoma	6.35e-05	0.000191	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK3—melanoma	6.31e-05	0.00019	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1B1—melanoma	6.29e-05	0.000189	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—melanoma	6.26e-05	0.000188	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1—melanoma	6.25e-05	0.000188	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MAPK1—melanoma	6.22e-05	0.000187	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—melanoma	6.22e-05	0.000187	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK3—melanoma	6.2e-05	0.000187	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	6.2e-05	0.000187	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTEN—melanoma	6.19e-05	0.000186	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—NRAS—melanoma	6.18e-05	0.000186	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—melanoma	6.14e-05	0.000185	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—BRAF—melanoma	6.09e-05	0.000183	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLA2G6—melanoma	6.05e-05	0.000182	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAP2K1—melanoma	6.04e-05	0.000182	CbGpPWpGaD
Niacin—QPRT—Disease—MAPK1—melanoma	6.01e-05	0.000181	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—melanoma	6.01e-05	0.000181	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CD—melanoma	6e-05	0.000181	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—PIK3CA—melanoma	5.95e-05	0.000179	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1—melanoma	5.93e-05	0.000178	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK3—melanoma	5.92e-05	0.000178	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—FN1—melanoma	5.9e-05	0.000178	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—MAPK1—melanoma	5.9e-05	0.000178	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—melanoma	5.9e-05	0.000177	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ABCB1—melanoma	5.89e-05	0.000177	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—KRAS—melanoma	5.88e-05	0.000177	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	5.84e-05	0.000176	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—melanoma	5.83e-05	0.000176	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTEN—melanoma	5.75e-05	0.000173	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGF2—melanoma	5.75e-05	0.000173	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAP2K1—melanoma	5.73e-05	0.000172	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CD—melanoma	5.69e-05	0.000171	CbGpPWpGaD
Niacin—QPRT—Disease—KRAS—melanoma	5.67e-05	0.000171	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—melanoma	5.65e-05	0.00017	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PIK3CA—melanoma	5.64e-05	0.00017	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—MAPK1—melanoma	5.63e-05	0.000169	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—EGF—melanoma	5.59e-05	0.000168	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—KRAS—melanoma	5.57e-05	0.000168	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGF2—melanoma	5.45e-05	0.000164	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—VCAN—melanoma	5.43e-05	0.000164	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PRKCA—melanoma	5.42e-05	0.000163	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CA—melanoma	5.4e-05	0.000162	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MDM2—melanoma	5.38e-05	0.000162	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ERCC2—melanoma	5.37e-05	0.000162	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KRAS—melanoma	5.32e-05	0.00016	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—melanoma	5.3e-05	0.00016	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—melanoma	5.23e-05	0.000157	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—melanoma	5.21e-05	0.000157	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—melanoma	5.17e-05	0.000156	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—melanoma	5.12e-05	0.000154	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MDM2—melanoma	5.1e-05	0.000153	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—melanoma	5.03e-05	0.000151	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—melanoma	5.03e-05	0.000151	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—melanoma	5e-05	0.00015	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—melanoma	4.97e-05	0.000149	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—melanoma	4.96e-05	0.000149	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—melanoma	4.91e-05	0.000148	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—melanoma	4.9e-05	0.000148	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—melanoma	4.89e-05	0.000147	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—melanoma	4.86e-05	0.000146	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—melanoma	4.82e-05	0.000145	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—melanoma	4.81e-05	0.000145	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—melanoma	4.81e-05	0.000145	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—melanoma	4.78e-05	0.000144	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—melanoma	4.78e-05	0.000144	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—melanoma	4.77e-05	0.000143	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—melanoma	4.74e-05	0.000143	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—melanoma	4.73e-05	0.000142	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—melanoma	4.69e-05	0.000141	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—melanoma	4.66e-05	0.00014	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—melanoma	4.64e-05	0.00014	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—melanoma	4.62e-05	0.000139	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—melanoma	4.61e-05	0.000139	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP17A1—melanoma	4.59e-05	0.000138	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—melanoma	4.56e-05	0.000137	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—melanoma	4.56e-05	0.000137	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—melanoma	4.55e-05	0.000137	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—melanoma	4.53e-05	0.000136	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—melanoma	4.53e-05	0.000136	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—melanoma	4.52e-05	0.000136	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—melanoma	4.52e-05	0.000136	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NFKB1—melanoma	4.5e-05	0.000135	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—melanoma	4.44e-05	0.000134	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—melanoma	4.41e-05	0.000133	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—melanoma	4.4e-05	0.000132	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—melanoma	4.36e-05	0.000131	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNA11—melanoma	4.33e-05	0.00013	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—melanoma	4.33e-05	0.00013	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—melanoma	4.31e-05	0.00013	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—melanoma	4.3e-05	0.000129	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—melanoma	4.29e-05	0.000129	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NFKB1—melanoma	4.27e-05	0.000128	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—melanoma	4.26e-05	0.000128	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—melanoma	4.24e-05	0.000128	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—melanoma	4.24e-05	0.000128	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FASN—melanoma	4.24e-05	0.000127	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACER3—melanoma	4.19e-05	0.000126	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—melanoma	4.18e-05	0.000126	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—melanoma	4.17e-05	0.000125	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—melanoma	4.09e-05	0.000123	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—melanoma	4.08e-05	0.000123	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—melanoma	4.06e-05	0.000122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—melanoma	4.04e-05	0.000122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NRAS—melanoma	4.03e-05	0.000121	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CD44—melanoma	4.03e-05	0.000121	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNAQ—melanoma	4.03e-05	0.000121	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—melanoma	3.99e-05	0.00012	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—melanoma	3.98e-05	0.00012	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—melanoma	3.87e-05	0.000117	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—melanoma	3.86e-05	0.000116	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1B1—melanoma	3.86e-05	0.000116	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—melanoma	3.83e-05	0.000115	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UGT2B10—melanoma	3.83e-05	0.000115	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NRAS—melanoma	3.82e-05	0.000115	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—melanoma	3.76e-05	0.000113	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—melanoma	3.73e-05	0.000112	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—melanoma	3.68e-05	0.000111	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK1—melanoma	3.68e-05	0.000111	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—melanoma	3.68e-05	0.000111	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK3—melanoma	3.66e-05	0.00011	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	3.65e-05	0.00011	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—melanoma	3.57e-05	0.000107	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HS3ST5—melanoma	3.56e-05	0.000107	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—melanoma	3.56e-05	0.000107	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK1—melanoma	3.49e-05	0.000105	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—melanoma	3.48e-05	0.000105	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—melanoma	3.47e-05	0.000104	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—melanoma	3.38e-05	0.000102	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NRAS—melanoma	3.34e-05	0.0001	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—melanoma	3.31e-05	9.97e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—melanoma	3.29e-05	9.9e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—melanoma	3.25e-05	9.78e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—melanoma	3.22e-05	9.69e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—melanoma	3.2e-05	9.62e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—melanoma	3.19e-05	9.6e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—melanoma	3.18e-05	9.56e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—melanoma	3.09e-05	9.29e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK1—melanoma	3.04e-05	9.15e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—melanoma	3.02e-05	9.1e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—melanoma	2.95e-05	8.88e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—melanoma	2.93e-05	8.8e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PRKCA—melanoma	2.92e-05	8.8e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ERCC2—melanoma	2.9e-05	8.73e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—melanoma	2.87e-05	8.64e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—melanoma	2.82e-05	8.5e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—melanoma	2.81e-05	8.45e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—melanoma	2.8e-05	8.42e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLCB4—melanoma	2.7e-05	8.13e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—melanoma	2.68e-05	8.06e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—melanoma	2.64e-05	7.94e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—melanoma	2.61e-05	7.84e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—melanoma	2.55e-05	7.68e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC6A11—melanoma	2.54e-05	7.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIP4K2A—melanoma	2.54e-05	7.64e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—melanoma	2.47e-05	7.43e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTAP—melanoma	2.47e-05	7.43e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—melanoma	2.44e-05	7.35e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—melanoma	2.29e-05	6.89e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—melanoma	2.21e-05	6.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PHGDH—melanoma	2.2e-05	6.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LUM—melanoma	2.2e-05	6.62e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPSE—melanoma	2.16e-05	6.5e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—melanoma	2.16e-05	6.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CUBN—melanoma	2.12e-05	6.38e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BSG—melanoma	2.05e-05	6.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CSPG4—melanoma	2.05e-05	6.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SDHD—melanoma	2.05e-05	6.16e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—melanoma	2.01e-05	6.06e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—melanoma	1.99e-05	5.98e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPAM—melanoma	1.98e-05	5.96e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—melanoma	1.98e-05	5.96e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—melanoma	1.76e-05	5.28e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—melanoma	1.74e-05	5.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLA2G6—melanoma	1.69e-05	5.07e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—melanoma	1.62e-05	4.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—melanoma	1.52e-05	4.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—VCAN—melanoma	1.51e-05	4.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP17A1—melanoma	1.28e-05	3.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNA11—melanoma	1.21e-05	3.63e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FASN—melanoma	1.18e-05	3.55e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—melanoma	1.16e-05	3.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNAQ—melanoma	1.12e-05	3.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CD44—melanoma	1.12e-05	3.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1B1—melanoma	1.08e-05	3.23e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—melanoma	1.07e-05	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—melanoma	8.85e-06	2.66e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—melanoma	8.74e-06	2.63e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PRKCA—melanoma	8.15e-06	2.45e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ERCC2—melanoma	8.08e-06	2.43e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—melanoma	6.38e-06	1.92e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—melanoma	6.16e-06	1.85e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—melanoma	5.61e-06	1.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—melanoma	5.54e-06	1.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—melanoma	4.89e-06	1.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—melanoma	4.85e-06	1.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—melanoma	4.23e-06	1.27e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—melanoma	2.98e-06	8.97e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—melanoma	2.44e-06	7.33e-06	CbGpPWpGaD
